What happens when 3,500 staffers lose their jobs due to FDA layoffs, venture capital (VC) term sheets shrink, and AI drug-discovery startups raise $600 million rounds? Executive recruiter William Holodnak (ex-Fidelity, global biotech headhunter) breaks down 2025’s wild hiring market—and how founders can still build A-teams. In this episode you’ll learn: - Why the April-1 FDA layoffs could delay approvals—and open new career doors for ex-regulators. - The three traits VCs deman...
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Why Every Medical Affairs Team Needs Their Own AI Agent in 2025
Why Most Healthcare Brands Fail (And How to Fix It)
4.5 Billion Molecules, One Mission: Cure the ‘Undruggable’ Diseases
What Separates Life Science Startup Winners from Losers?
Free AI-powered recaps of Life Sciences 360 and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.